Invention Grant
- Patent Title: Nanoparticulate meloxicam formulations
-
Application No.: US15950367Application Date: 2018-04-11
-
Publication No.: US10463673B2Publication Date: 2019-11-05
- Inventor: Eugene R. Cooper , Tuula Ryde , John Pruitt , Laura Kline
- Applicant: Recro Pharma, Inc.
- Applicant Address: US PA Malvern
- Assignee: Recro Pharma, Inc.
- Current Assignee: Recro Pharma, Inc.
- Current Assignee Address: US PA Malvern
- Agency: Stradley Ronon Stevens & Young, LLP
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K31/5415 ; A61K9/00 ; A61K9/51 ; A61K9/10
Abstract:
The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
Public/Granted literature
- US20180228809A1 Nanoparticulate Meloxicam Formulations Public/Granted day:2018-08-16
Information query
